Oncology

< Back

Overview

The Oncology research area is composed by nine groups addressing the principal unsolved issues in cancer. Their research covers fields such as child and adolescent cancer, melanoma, Gynecology, Urology, cancer stem cells and the molecular mechanisms of the tumor pathologies.

There are also three groups from the CIBBIM-Nanomedicine. These groups study the use of nanotechnology in biomedical applications to improve therapeutic strategies and diagnostics.

Publications

120
total
757.123
impact factor
6.309
average impact factor

Director: Josep Sánchez de Toledo

In 2017, the group of Translational Research in Child and Adolescent Cancer has kept expanding their research lines, namely research on Soft Tissue Sarcomas (e.g. Rhabdomyosarcoma), Neural tumours (e.g. Neuroblastoma, Ependymoma) and the program of personalized medicine. This research yielded the publication of 21 new international papers with an accumulated impact factor (JCI 2016) of 124,831. Moreover, within this period the group has been awarded with 2 new grants from Instituto de Salud Carlos III (PI17/00564) and Asociación Española Contra el Cáncer-Junta de Barcelona that will start on 2018. In addition, the group has continued with the consolidated collaborations with biotech companies with the aim of testing and developing new therapeutic tools against the most aggressive pediatric solid tumors.

VHIR Annual Report 2017